 | This article is rated Start-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | ||||||||||||||||||||
| |||||||||||||||||||||
 | Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Fosbretabulin.
|
Link added
editI've added a link back to the main Combretastatin page, as there's much more info about it on there. I wonder if this stub is actually needed, or could be merged back into the main combretastatin page? KatArney (talk) 12:27, 4 May 2011 (UTC)
- Better IMO to keep this separate. Combretastatin is about a whole family of natural molecules. This CA4P is about one specific experimental drug which has undergone numerous clinical trials; which should be summarised (here). - Rod57 (talk) 15:13, 16 February 2017 (UTC)
List of references
editThe following list of references was added to the article, but apparently are not used to support specific content in the article. I'm moving them here in case anyone would like to use them to expand this article. -- Ed (Edgar181) 19:19, 16 August 2011 (UTC)
- Beauregard, D; Hill, S; Chaplin, D; Brindle, K. The susceptibility of tumors to the antivascular drug combretastatin A4 phosphate correlated with vascular permeability Cancer Research, 2001, 61, 6811-6815.
- Salmon, B. “Characterizing the Tumor Response to Treatment with Combretastatin A-4 Phosphate” Int. J. Radiation Oncology Biol. Phys, 2007, 68, 1, 211-217
Two isomers ?
editCombretastatin A-4 says it comes in two isomers - only cis being active. Does this apply to CA4P too ? - Rod57 (talk) 11:20, 17 February 2017 (UTC)